Загрузка...
Intratumoral immunosuppression profiles in 11q‐deleted neuroblastomas provide new potential therapeutic targets
High‐risk neuroblastoma (NB) patients with 11q deletion frequently undergo late but consecutive relapse cycles with fatal outcome. To date, no actionable targets to improve current multimodal treatment have been identified. We analyzed immune microenvironment and genetic profiles of high‐risk NB cor...
Сохранить в:
| Опубликовано в: : | Mol Oncol |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7858123/ https://ncbi.nlm.nih.gov/pubmed/33252831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12868 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|